CMV colitis: Difference between revisions
| Line 8: | Line 8: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
*Bacterial Gastroenteritis | |||
*Campylobacter Infections | |||
*Clostridium Difficile Colitis | |||
*Colon Cancer | |||
*Crohn Disease | |||
*Cryptosporidiosis | |||
*Mycobacterium Avium-Intracellulare | |||
*Toxic Megacolon | |||
*Ulcerative Colitis | |||
*Viral Gastroenteritis | |||
==Diagnosis== | ==Diagnosis== | ||
Revision as of 22:50, 29 June 2015
Background
- CMV is part of the Herpesviridae family
- 50-80% of the world's population is seropositive for CMV
- Causes a mild or undetectable infection in immunocompetent hosts
- Severe systemic illness is found in immunosuppressed hosts
Clinical Presentation
Differential Diagnosis
- Bacterial Gastroenteritis
- Campylobacter Infections
- Clostridium Difficile Colitis
- Colon Cancer
- Crohn Disease
- Cryptosporidiosis
- Mycobacterium Avium-Intracellulare
- Toxic Megacolon
- Ulcerative Colitis
- Viral Gastroenteritis
Diagnosis
Management
Disposition
- Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
- Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)